Health-related quality of life (HRQoL) in the phase III QUAZAR-AML-001 trial of CC-486 as maintenance therapy for patients with acute myeloid leukemia (AML) in first remission following induction chemotherapy (IC).

Roboz, GJ; Dohner, H; Pocock, C; Dombret, H; Ravandi, F; Jang, JH; Selleslag, D; Mayer, J; Martens, UM; Liesveld, J; del Castillo, TB; Wang, MC; La Torre, I; Skikne, B; Kumar, K; Dong, Q; Braverman, J; Nehme, SA; Beach, CL; Wei, A

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):